Geeta Molecular Diagnostic Lab Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
- Paid Up Capital ₹ 0.40 M
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.70 M
- Revenue Growth 8.04%
- Profit Growth 12.25%
- Ebitda -7.24%
- Net Worth 49.11%
- Total Assets 8.59%
About Geeta Molecular Diagnostic Lab
Geeta Molecular Diagnostic Lab Private Limited (GMDLPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 September 2008 and has a history of 16 years and four months. Its registered office is in Darbhanga, Bihar, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹0.70 M.
Ashok Singh, Shamse Alam, Deepak Prasad, and One other member serve as directors at the Company.
Company Details
- Location
Darbhanga, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85100BR2008PTC013916
- Company No.
013916
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Geeta Molecular Diagnostic Lab?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Singh  | Director | 11-Sep-2008 | Current |
| Shamse Alam | Director | 05-Oct-2010 | Current |
| Deepak Prasad | Director | 05-Oct-2010 | Current |
| Nirmala Singh | Director | 11-Sep-2008 | Current |
Financial Performance of Geeta Molecular Diagnostic Lab.
Geeta Molecular Diagnostic Lab Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 8.04% increase. The company also saw a substantial improvement in profitability, with a 12.25% increase in profit. The company's net worth Soared by an impressive increase of 49.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Geeta Molecular Diagnostic Lab?
In 2019, Geeta Molecular Diagnostic Lab had a promoter holding of 87.50% and a public holding of 12.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.70 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Mar 2012 | Bank Of Baroda | ₹0.70 M | Open |
How Many Employees Work at Geeta Molecular Diagnostic Lab?
Geeta Molecular Diagnostic Lab has a workforce of 6 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Geeta Molecular Diagnostic Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geeta Molecular Diagnostic Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.